Studies related to Interleukin 6 and Curcumin

Efficacy And Safety Of Meriva®, A Curcumin-phosphatidylcholine Complex, During Extended Administration In Osteoarthritis Patients

Effect Decrease
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 100
Sex Both Genders
Age Range 45-64
Body Types Overweight, Average
Notes for this study:
Curcumin, dosed at 1,000mg MERIVA (curcumin bound to phosphatidylcholine) taken in two divided dosages of 500mg, was safe and effective over a period of 8 months in alleviating clinical and biochemical symptoms of osteoarthritis in a population of middle-aged (43+/-2) persons with osteoarthritis.

Reductions were noted in IL-6 (27%), IL-1b (65%), and cell adhesion factors.

Full details on all 5 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.